Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type Interaction Map description Network Comparison Type Rank Gene Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1675 to 1724 of 3228 in total 
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitochondrial import receptor subunit tom20 homolog (mitochondrial 20 kda outer membrane protein) (outer mitochondrial membrane receptor tom20). [source:swissprot;acc:q15388]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
529\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8600.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9792.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13866\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitochondrial precursor proteins import receptor (translocase of outer membrane tom70). [source:swissprot;acc:o94826]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1616\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6035.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6464.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07106\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitochondrial processing peptidase alpha subunit, mitochondrial precursor (ec 3.4.24.64) (alpha-mpp) (p-55) (ha1523). [source:swissprot;acc:q10713]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
433\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5244.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6036.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15091\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitochondrial processing peptidase beta subunit, mitochondrial precursor (ec 3.4.24.64) (beta-mpp) (p-52). [source:swissprot;acc:o75439]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
432\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5244.71\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6036.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15093\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l17; lyst-interacting protein lip2. [source:refseq;acc:nm\_022061]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2253\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3629.21\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3467.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04664\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l18. [source:refseq;acc:nm\_014161]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1906\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5396.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5733.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06251\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l2. [source:refseq;acc:nm\_015950]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2068\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3602.75\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3411.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05616\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l22. [source:refseq;acc:nm\_014180]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2647\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4778.28\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4732.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00975\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l24. [source:refseq;acc:nm\_024540]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1458\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5672.25\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6104.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07612\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l30 isoform a. [source:refseq;acc:nm\_145212]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1576\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5923.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6349.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07181\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l4 isoform a. [source:refseq;acc:nm\_015956]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2039\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3646.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3449.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05696\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitochondrial ribosomal protein s7; 30s ribosomal protein s7 homolog. [source:refseq;acc:nm\_015971]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3016\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitochondrial ribosome recycling factor. [source:refseq;acc:nm\_138777]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1015\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5791.82\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6340.86\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0948\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitochondrial solute carrier protein. [source:refseq;acc:nm\_016612]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2915\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitochondrial solute carrier protein. [source:refseq;acc:nm\_145305]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
119\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
21185\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.34491\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitochondrial translational release factor 1-like. [source:refseq;acc:nm\_019041]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
885\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5168.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5696.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10219\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitogen-activated protein kinase 1 (ec 2.7.1.37) (extracellular signal-regulated kinase 2) (erk-2) (mitogen-activated protein kinase 2) (map kinase 2) (mapk 2) (p42-mapk) (ert1). [source:swissprot;acc:p28482]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1389\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6079.13\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6554.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07825\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitogen-activated protein kinase 12 (ec 2.7.1.37) (extracellular signal-regulated kinase 6) (erk-6) (erk5) (stress-activated protein kinase-3) (mitogen-activated protein kinase p38 gamma) (map kinase p38 gamma). [source:swissprot;acc:p53778]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
471\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
mitogen-activated protein kinase 14 (ec 2.7.1.37) (mitogen-activated protein kinase p38alpha) (map kinase p38alpha) (cytokine suppressive anti-inflammatory drug binding protein) (csaid binding protein) (csbp) (max-interacting protein 2) (map kinase mxi2) (sapk2a). [source:swissprot;acc:q16539]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
482\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitogen-activated protein kinase 3 (ec 2.7.1.37) (extracellular signal-regulated kinase 1) (erk-1) (insulin-stimulated map2 kinase) (map kinase 1) (mapk 1) (p44-erk1) (ert2) (p44-mapk) (microtubule- associated protein-2 kinase). [source:swissprot;acc:p27361]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1373\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6079.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6556.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07833\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitogen-activated protein kinase kinase 1 interacting protein 1 (mek binding partner 1) (mp1) (pro2783). [source:swissprot;acc:q9uha4]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3084\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitogen-activated protein kinase kinase kinase 5 (ec 2.7.1.-) (mapk/erk kinase kinase 5) (mek kinase 5) (mekk 5) (apoptosis signal- regulating kinase 1) (ask-1). [source:swissprot;acc:q99683]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1387\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6079.46\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6555.4\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07829\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
mitogen-activated protein kinase kinase kinase 6 (ec 2.7.1.-). [source:swissprot;acc:o95382]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1377\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitogen-activated protein kinase kinase kinase 7 (ec 2.7.1.-) (transforming growth factor-beta-activated kinase 1) (tgf-beta- activated kinase 1). [source:swissprot;acc:o43318]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1214\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6001.16\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6515.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08577\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitogen-activated protein kinase kinase kinase 7 interacting protein 1 (tak1-binding protein 1). [source:swissprot;acc:q15750]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1310\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6051.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6544.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08146\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitogen-activated protein kinase kinase kinase 7 interacting protein 2 isoform 1; tak1-binding protein 2. [source:refseq;acc:nm\_015093]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1056\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4757.46\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5198.91\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09279\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitogen-activated protein kinase-activated protein kinase 3; mapkap kinase 3. [source:refseq;acc:nm\_004635]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
481\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitotic checkpoint protein bub3. [source:swissprot;acc:o43684]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1168\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5470.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5949.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08757\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitotic checkpoint serine/threonine-protein kinase bub1 beta (ec 2.7.1.-) (hbubr1) (mad3/bub1-related protein kinase) (mitotic checkpoint kinase mad3l). [source:swissprot;acc:o60566]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1271\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5528.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5985.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08265\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitotic spindle assembly checkpoint protein mad2a (mad2-like 1) (hsmad2). [source:swissprot;acc:q13257]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1190\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6599.84\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7174.29\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08704\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mitotic spindle assembly checkpoint protein mad2b (mad2-like 2) (hrev7). [source:swissprot;acc:q9ui95]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
877\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5797.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6391.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10243\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mki67 (fha domain) interacting nucleolar phosphoprotein; nucleolar phosphoprotein nopp34; nucleolar protein interacting with the fha domain of pki-67. [source:refseq;acc:nm\_032390]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
412\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3594.31\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4169.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16015\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mln 64 protein (star-related lipid transfer protein 3) (stard3) (start domain-containing protein 3) (cab1 protein). [source:swissprot;acc:q14849]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1721\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5458.12\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5830.76\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06827\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
mln64 n-terminal domain homolog (stard3 n-terminal like protein). [source:swissprot;acc:o95772]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1724\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mms19-like (met18 homolog, s. cerevisiae); homolog of yeast mms19; mms19 (met18 s. cerevisiae)-like. [source:refseq;acc:nm\_022362]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1540\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6360.13\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6825.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07315\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mo25 protein (cgi-66). [source:swissprot;acc:q9y376]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2976\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
mo25-like protein. [source:swissprot;acc:q9h9s4]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3116\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
mob-lak. [source:refseq;acc:nm\_130807]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2812\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
molybdenum cofactor synthesis protein 2 large subunit (molybdopterin synthase large subunit) (mpt synthase large subunit) (mocs2b) (moco1- b). [source:swissprot;acc:o96007]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1646\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6079.19\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6503.12\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06973\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
molybdenum cofactor synthesis protein 3 (molybdopterin synthase sulfurylase) (mpt synthase sulfurylase). [source:swissprot;acc:o95396]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1650\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mondoa. [source:refseq;acc:nm\_014938]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2800\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
monoglyceride lipase; lysophospholipase-like. [source:refseq;acc:nm\_007283]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1037\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6544.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7159.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.094\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mosaic protein lgn. [source:swissprot;acc:p81274]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
279\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3119.98\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2579.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.20953\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mothers against decapentaplegic homolog 1 (smad 1) (mothers against dpp homolog 1) (mad-related protein 1) (transforming growth factor- beta signaling protein-1) (bsp-1) (hsmad1) (jv4-1). [source:swissprot;acc:q15797]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2323\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6773.67\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7075.51\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04456\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
mothers against decapentaplegic homolog 2 (smad 2) (mothers against dpp homolog 2) (mad-related protein 2) (hmad-2) (jv18-1) (hsmad2). [source:swissprot;acc:q15796]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2322\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
mothers against decapentaplegic homolog 3 (smad 3) (mothers against dpp homolog 3) (mad3) (hmad-3) (mmad3) (jv15-2) (hsmad3). [source:swissprot;acc:q92940]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2325\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mothers against decapentaplegic homolog 4 (smad 4) (mothers against dpp homolog 4) (deletion target in pancreatic carcinoma 4) (hsmad4). [source:swissprot;acc:q13485]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2368\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5265.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5492.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04298\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mothers against decapentaplegic homolog 5 (smad 5) (mothers against dpp homolog 5) (smad5) (hsmad5) (jv5-1). [source:swissprot;acc:q99717]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2332\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6773.67\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7075.51\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04456\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
mothers against decapentaplegic homolog 9 (smad 9) (mothers against dpp homolog 9) (smad9) (madh6). [source:swissprot;acc:o15198]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2331\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mothers against decapentaplegic homolog interacting protein (madh-interacting protein) (smad anchor for receptor activation) (receptor activation anchor) (hsara) (novel serine protease) (nsp). [source:swissprot;acc:o95405]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2887\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/